Gralla Rj
- Oncology
- Surgery
- Pulmonary and Respiratory Medicine
- Molecular Biology
- Pathology and Forensic Medicine
- Co-authors
- Golbey RbMark G. KrisD. P. KelsenCasper EsEsteban CvitkovicYoung CwWittes ReSusan Groshen
- Topics
- Cancer therapeutics and mechanisms (8 papers)Cancer Treatment and Pharmacology (6 papers)Lung Cancer Treatments and Mutations (6 papers)
- Journals
- PubMed
- Partner nations
- United States
In The Last Decade
Gralla Rj
27 papers receiving 346 citations
Peers
Comparison fields: 5 of 61
- Oncology 181
- Surgery 128
- Pulmonary and Respiratory Medicine 123
- Molecular Biology 80
- Pathology and Forensic Medicine 60
Countries citing papers authored by Gralla Rj
This map shows the geographic impact of Gralla Rj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gralla Rj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gralla Rj more than expected).
Fields of papers citing papers by Gralla Rj
This network shows the impact of papers produced by Gralla Rj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gralla Rj. The network helps show where Gralla Rj may publish in the future.
Co-authorship network of co-authors of Gralla Rj
This figure shows the co-authorship network connecting the top 25 collaborators of Gralla Rj. A scholar is included among the top collaborators of Gralla Rj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gralla Rj. Gralla Rj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Methodology in anti-emetic trials. | 13 |
| 2 | An outline of anti-emetic treatment. | 11 |
| 3 | Phase II trial of esorubicin in patients with advanced non-small cell lung cancer. | 5 |
| 4 | Phase II trial of oral piritrexim (BW301U) in patients with stage III non-small cell lung cancer. | 9 |
| 5 | Adenocarcinoma of unknown primary origin: treatment with vindesine and doxorubicin. | 16 |
| 6 | Phase II trial of 4'-epi-doxorubicin in patients with non-small cell lung cancer. | 19 |
| 7 | Phase II trial of PCNU in non-small cell lung cancer. | 3 |
| 8 | Phase I trial of PCNU. | 0 |
| 9 | Phase II trial of PALA in hypernephroma and urinary bladder cancer. | 10 |
| 10 | Phase II evaluation of vindesine sulfate in patients with advanced sarcomas. | 4 |
| 11 | Chlorozotocin: phase II evaluation in patients with advanced sarcomas. | 4 |
| 12 | A phase II trial of m-AMSA in patients with small-cell lung cancer. | 6 |
| 13 | Phase II evaluation of N-(phosphonacetyl)-L-aspartic acid (PALA) in patients with non-small cell carcinoma of the lung. | 12 |
| 14 | Phase II evaluation of metoprine in patients with non-small-cell lung carcinoma. | 2 |
| 15 | Phase II evaluation of vindesine in patients with advanced colorectal carcinoma. | 5 |
| 16 | Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis. | 56 |
| 17 | Phase II trial of vindesine in patients with germ-cell tumors. | 5 |
| 18 | Phase II evaluation of chlorozotocin in patients with non-small cell carcinoma of the lung. | 4 |
| 19 | Phase II evaluation of pyrazofurin in patients with metastatic sarcoma. | 6 |
| 20 | Phase II evaluation of pyrazofurin in patients with carcinoma of the lung. | 8 |
About Gralla Rj
Gralla Rj is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 29 papers that have together received 389 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (8 papers), Cancer Treatment and Pharmacology (6 papers) and Lung Cancer Treatments and Mutations (6 papers). The work is most often cited by research in Oncology (181 citations), Pulmonary and Respiratory Medicine (123 citations) and Pathology and Forensic Medicine (60 citations). Gralla Rj has collaborated with scholars based in United States. Frequent co-authors include Golbey Rb, Mark G. Kris, D. P. Kelsen, Casper Es, Esteban Cvitkovic, Young Cw, Wittes Re, Susan Groshen, Alan Yagoda and Young Cw. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.